{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:03:19Z","timestamp":1794952999073,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"crossref","award":["RGP1\/263\/46"],"award-info":[{"award-number":["RGP1\/263\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15471-4","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T01:33:57Z","timestamp":1766799237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of novel FGFR1 inhibitors for oral squamous cell carcinoma using a multi-class QSAR model, virtual screening, and molecular dynamics simulations"],"prefix":"10.1186","volume":"26","author":[{"given":"Samuel Ebele","family":"Udeabor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ishfaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahi Jahan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashail M.M","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abosofyan Salih Atta","family":"Elfadeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidozie Ifechi","family":"Onwuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Abubaker Abbas","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malaz M","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"15471_CR1","first-page":"10","volume":"15","author":"SA Kumar","year":"2020","unstructured":"Kumar SA, et al. Oral squamous cell carcinoma (OSCC) in humans: etiological Factors, diagnostic and therapeutic relevance. Res J Biotechnol. 2020;15:10.","journal-title":"Res J Biotechnol"},{"issue":"1","key":"15471_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15(1):44.","journal-title":"Int J Oral Sci"},{"key":"15471_CR3","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.oraloncology.2020.104799","volume":"107","author":"A Almangush","year":"2020","unstructured":"Almangush A, et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 2020;107:104799.","journal-title":"Oral Oncol"},{"issue":"3","key":"15471_CR4","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.4317\/medoral.20347","volume":"20","author":"C Carreras-Torras","year":"2015","unstructured":"Carreras-Torras C, Gay-Escoda C. Techniques for early diagnosis of oral squamous cell carcinoma: systematic review. Med Oral Patologia Oral Y Cir Bucal. 2015;20(3):e305.","journal-title":"Med Oral Patologia Oral Y Cir Bucal"},{"issue":"3","key":"15471_CR5","first-page":"e387","volume":"26","author":"AKA Ferreira","year":"2020","unstructured":"Ferreira AKA, et al. Survival and prognostic factors in patients with oral squamous cell carcinoma. Med Oral Patologia Oral Y Cir Bucal. 2020;26(3):e387.","journal-title":"Med Oral Patologia Oral Y Cir Bucal"},{"issue":"4","key":"15471_CR6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s43440-025-00745-2","volume":"77","author":"S Irannejadrankouhi","year":"2025","unstructured":"Irannejadrankouhi S, Mivehchi H, Eskandari-Yaghbastlo A, Nejati ST, Emrahoglu S, Azarang F, et al. Novel receptor tyrosine kinase-targeted strategies to overcome resistance in oral squamous cell carcinoma. Pharmacol Rep. 2025;77(4):962\u201382. Epub 2025 Jun 5. PMID: 40468099. https:\/\/doi.org\/10.1007\/s43440-025-00745-2.","journal-title":"Pharmacol Rep"},{"issue":"10","key":"15471_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2012.07.001","volume":"33","author":"G Liang","year":"2012","unstructured":"Liang G, et al. Anticancer molecules targeting fibroblast growth factor receptors. Trends Pharmacol Sci. 2012;33(10):531\u201341.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"15471_CR8","doi-asserted-by":"publisher","first-page":"e1549","DOI":"10.1002\/wsbm.1549","volume":"14","author":"DM Ornitz","year":"2022","unstructured":"Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mech Disease. 2022;14(4):e1549.","journal-title":"WIREs Mech Disease"},{"issue":"1","key":"15471_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, et al. FGF\/FGFR signaling in health and disease. Signal Transduct Target Therapy. 2020;5(1):181.","journal-title":"Signal Transduct Target Therapy"},{"issue":"4","key":"15471_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1083\/jcb.200505098","volume":"171","author":"W Xian","year":"2005","unstructured":"Xian W, et al. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol. 2005;171(4):663\u201373.","journal-title":"J Cell Biol"},{"key":"15471_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.lungcan.2019.04.023","volume":"132","author":"J Vad-Nielsen","year":"2019","unstructured":"Vad-Nielsen J, et al. Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells. Lung Cancer. 2019;132:132\u201340.","journal-title":"Lung Cancer"},{"issue":"10","key":"15471_CR12","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1080\/17512433.2021.1947246","volume":"14","author":"M Repetto","year":"2021","unstructured":"Repetto M, et al. Selective FGFR\/FGF pathway inhibitors: Inhibition strategies, clinical activities, resistance mutations, and future directions. Expert Rev Clin Pharmacol. 2021;14(10):1233\u201352.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"12","key":"15471_CR13","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/13543784.2020.1838484","volume":"29","author":"SR Chandana","year":"2020","unstructured":"Chandana SR, Babiker HM, Mahadevan D. Clinical complexity of utilizing FGFR inhibitors in cancer therapeutics. Expert Opin Investig Drugs. 2020;29(12):1413\u201329.","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl 2","key":"15471_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12864-017-3503-2","volume":"18","author":"H-H Hsu","year":"2017","unstructured":"Hsu H-H, et al. An integrated approach with new strategies for QSAR models and lead optimization. BMC Genomics. 2017;18(Suppl 2):104.","journal-title":"BMC Genomics"},{"issue":"2","key":"15471_CR15","first-page":"e1568","volume":"12","author":"M Staszak","year":"2022","unstructured":"Staszak M, et al. Machine learning in drug design: use of artificial intelligence to explore the chemical structure\u2013biological activity relationship. Wiley Interdisciplinary Reviews: Comput Mol Sci. 2022;12(2):e1568.","journal-title":"Wiley Interdisciplinary Reviews: Comput Mol Sci"},{"issue":"2","key":"15471_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-023-00832-0","volume":"23","author":"A Tropsha","year":"2024","unstructured":"Tropsha A, et al. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat Rev Drug Discovery. 2024;23(2):141\u201355.","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"15471_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/PPO.0000000000000615","volume":"28","author":"Z Wang","year":"2022","unstructured":"Wang Z, Anderson KS. Therapeutic targeting of FGFR signaling in head and neck cancer. Cancer J. 2022;28(5):354\u201362.","journal-title":"Cancer J"},{"issue":"D1","key":"15471_CR18","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil B, et al. The chembl database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 2024;52(D1):D1180\u201392.","journal-title":"Nucleic Acids Res"},{"key":"15471_CR19","doi-asserted-by":"publisher","first-page":"110993","DOI":"10.1016\/j.radonc.2025.110993","volume":"209","author":"J Li","year":"2025","unstructured":"Li J, He HG, Guan C, Ding Y, Hu X Dynamic joint prediction model of severe radiation-induced oral mucositis among nasopharyngeal carcinoma: a prospective longitudinal study. Radiother Oncol. 2025;209:110993. Epub 2025 Jun 20. PMID: 40544870. https:\/\/doi.org\/10.1016\/j.radonc.2025.110993.","journal-title":"Radiother Oncol"},{"issue":"1","key":"15471_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13755-025-00344-8","volume":"13","author":"W Zheng","year":"2025","unstructured":"Zheng W, et al. GEP-DNN4Mol: automatic chemical molecular design based on deep neural networks and gene expression programming. Health Inform Sci Syst. 2025;13(1):31.","journal-title":"Health Inform Sci Syst"},{"issue":"1","key":"15471_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13321-020-00456-1","volume":"12","author":"AP Bento","year":"2020","unstructured":"Bento AP, et al. An open source chemical structure curation pipeline using RDKit. J Cheminform. 2020;12(1):51.","journal-title":"J Cheminform"},{"issue":"1","key":"15471_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13321-020-00445-4","volume":"12","author":"A Capecchi","year":"2020","unstructured":"Capecchi A, Probst D, Reymond J-L. One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome. J Cheminform. 2020;12(1):43.","journal-title":"J Cheminform"},{"issue":"21","key":"15471_CR23","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.3390\/electronics12214423","volume":"12","author":"J Sadaiyandi","year":"2023","unstructured":"Sadaiyandi J, et al. Stratified sampling-based deep learning approach to increase prediction accuracy of unbalanced dataset. Electronics. 2023;12(21):4423.","journal-title":"Electronics"},{"issue":"1","key":"15471_CR24","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/s41467-025-61112-6","volume":"16","author":"J Yan","year":"2025","unstructured":"Yan J, et al. Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of \u03b2-catenin. Nat Commun. 2025;16(1):5997.","journal-title":"Nat Commun"},{"key":"15471_CR25","unstructured":"Anders CJ. Debugging learning algorithms Understanding and correcting machine learning models. Technische Universitaet Berlin (Germany); 2024."},{"issue":"01","key":"15471_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.38094\/jastt20165","volume":"2","author":"B Charbuty","year":"2021","unstructured":"Charbuty B, Abdulazeez A. Classification based on decision tree algorithm for machine learning. J Appl Sci Technol Trends. 2021;2(01):20\u20138.","journal-title":"J Appl Sci Technol Trends"},{"key":"15471_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.58496\/BJML\/2024\/007","volume":"2024","author":"HA Salman","year":"2024","unstructured":"Salman HA, Kalakech A, Steiti A. Random forest algorithm overview. Babylon J Mach Learn. 2024;2024:69\u201379.","journal-title":"Babylon J Mach Learn"},{"issue":"10","key":"15471_CR28","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.1109\/TNNLS.2022.3212859","volume":"34","author":"SM Mastelini","year":"2022","unstructured":"Mastelini SM, et al. Online extra trees regressor. IEEE Trans Neural Networks Learn Syst. 2022;34(10):6755\u201367.","journal-title":"IEEE Trans Neural Networks Learn Syst"},{"issue":"3","key":"15471_CR29","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s10462-020-09896-5","volume":"54","author":"C Bent\u00e9jac","year":"2021","unstructured":"Bent\u00e9jac C, Cs\u00f6rg\u0151 A, Mart\u00ednez-Mu\u00f1oz G. A comparative analysis of gradient boosting algorithms. Artif Intell Rev. 2021;54(3):1937\u201367.","journal-title":"Artif Intell Rev"},{"key":"15471_CR30","doi-asserted-by":"crossref","unstructured":"Stawiski M et al. Using the Light gradient boosting machine for prediction in QSAR models. in International Joint Conference on Advances in Computational Intelligence. 2022. Springer.","DOI":"10.1007\/978-981-99-1435-7_10"},{"issue":"20","key":"15471_CR31","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/BF03183737","volume":"50","author":"H Mei","year":"2005","unstructured":"Mei H, et al. Support vector machine applied in QSAR modelling. Chin Sci Bull. 2005;50(20):2291\u20136.","journal-title":"Chin Sci Bull"},{"issue":"3","key":"15471_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/ci049628+","volume":"45","author":"P Itskowitz","year":"2005","unstructured":"Itskowitz P, Tropsha A. K nearest neighbors QSAR modeling as a variational problem: theory and applications. J Chem Inf Model. 2005;45(3):777\u201385.","journal-title":"J Chem Inf Model"},{"issue":"11","key":"15471_CR33","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1021\/ci400331p","volume":"53","author":"J Fang","year":"2013","unstructured":"Fang J, et al. Predictions of BuChE inhibitors using support vector machine and Naive bayesian classification techniques in drug discovery. J Chem Inf Model. 2013;53(11):3009\u201320.","journal-title":"J Chem Inf Model"},{"key":"15471_CR34","unstructured":"Bustamam A et al. Comparison accuracy of Multi-Layer Perceptron and DNN in QSAR classification for acetylcholinesterase inhibitors. in 2021 International Conference on Artificial Intelligence and Mechatronics Systems (AIMS). 2021. IEEE."},{"issue":"1","key":"15471_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco D, Jurman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21(1):6.","journal-title":"BMC Genomics"},{"issue":"11","key":"15471_CR36","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ. ZINC 15\u2013ligand discovery for everyone. J Chem Inf Model. 2015;55(11):2324\u201337.","journal-title":"J Chem Inf Model"},{"key":"15471_CR37","unstructured":"Protein data bank: the single global archive for 3D macromolecular structure data. Nucleic Acids Res, 2019; 47(D1): D520\u20138."},{"issue":"1","key":"15471_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70\u201382.","journal-title":"Protein Sci"},{"key":"15471_CR39","unstructured":"Pawar RP, Rohane SH. Role of autodock vina in PyRx molecular docking. 2021."},{"issue":"1","key":"15471_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.24198\/ijcb.v2i1.46322","volume":"2","author":"U Baroroh","year":"2023","unstructured":"Baroroh U, et al. Molecular interaction analysis and visualization of protein-ligand Docking using biovia discovery studio visualizer. Indonesian J Comput Biology (IJCB). 2023;2(1):22\u201330.","journal-title":"Indonesian J Comput Biology (IJCB)"},{"issue":"11","key":"15471_CR41","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1021\/acs.jctc.0c00744","volume":"16","author":"B Kohnke","year":"2020","unstructured":"Kohnke B, Kutzner C, Grubm\u00fcller H. A GPU-accelerated fast multipole method for GROMACS: performance and accuracy. J Chem Theory Comput. 2020;16(11):6938\u201349.","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"15471_CR42","doi-asserted-by":"publisher","first-page":"e4413","DOI":"10.1002\/pro.4413","volume":"31","author":"H Guterres","year":"2022","unstructured":"Guterres H, et al. CHARMM-GUI high\u2010throughput simulator for efficient evaluation of protein\u2013ligand interactions with different force fields. Protein Sci. 2022;31(9):e4413.","journal-title":"Protein Sci"},{"key":"15471_CR43","doi-asserted-by":"publisher","first-page":"109245","DOI":"10.1016\/j.compbiomed.2024.109245","volume":"183","author":"S Moradi","year":"2024","unstructured":"Moradi S, et al. A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation. Comput Biol Med. 2024;183:109245.","journal-title":"Comput Biol Med"},{"key":"15471_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.molstruc.2019.02.071","volume":"1185","author":"W Xie","year":"2019","unstructured":"Xie W, et al. 3D-QSAR and molecular Docking studies of aminopyrimidine derivatives as novel three-targeted Lck\/Src\/KDR inhibitors. J Mol Struct. 2019;1185:240\u201358.","journal-title":"J Mol Struct"},{"key":"15471_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.sajb.2024.06.028","volume":"171","author":"PS Ramalingam","year":"2024","unstructured":"Ramalingam PS, et al. Computational identification and experimental validation of potential inhibitors of JAK1 kinase from natural source for the effective treatment of colorectal adenocarcinoma. South Afr J Bot. 2024;171:412\u201324.","journal-title":"South Afr J Bot"},{"key":"15471_CR46","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, et al. Identification of cuproptosis-related LncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198.","journal-title":"Comput Biol Med"},{"issue":"185","key":"15471_CR47","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.24976\/Discov.Med.202436185.118","volume":"36","author":"Q Li","year":"2024","unstructured":"Li Q, Zhan X, Tan Y. Identification of KIF26B as a tumor marker for oral squamous cell carcinoma. Discov Med. 2024;36(185):1280\u20138.","journal-title":"Discov Med"},{"issue":"3","key":"15471_CR48","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/cimb45030137","volume":"45","author":"PS Ramalingam","year":"2023","unstructured":"Ramalingam PS, et al. Identification of dietary bioflavonoids as potential inhibitors against KRAS G12D Mutant-Novel insights from Computer-Aided drug discovery. Curr Issues Mol Biol. 2023;45(3):2136\u201356.","journal-title":"Curr Issues Mol Biol"},{"key":"15471_CR49","doi-asserted-by":"publisher","unstructured":"Gharat SA, Momin M, Bhavsar C. Oral Squamous cell carcinoma: current treatment strategies and Nanotechnology-based approaches for prevention and therapy. Crit Rev Ther Drug Carrier Syst. 2016;33(4):363\u2013400. 2016016272. PMID: 27910740. https:\/\/doi.org\/10.1615\/CritRevTherDrugCarrierSyst.","DOI":"10.1615\/CritRevTherDrugCarrierSyst"},{"key":"15471_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.suronc.2019.09.001","volume":"31","author":"L Liu","year":"2019","unstructured":"Liu L, et al. Progress in targeted therapeutic drugs for oral squamous cell carcinoma. Surg Oncol. 2019;31:90\u20137.","journal-title":"Surg Oncol"},{"issue":"1","key":"15471_CR51","first-page":"1","volume":"12","author":"A Jain","year":"2021","unstructured":"Jain A, et al. A computational approach to identify the mutations in the genes of the RTK signaling pathway and their possible association with oral squamous cell carcinoma. Middle East J Cancer. 2021;12(1):1\u20139.","journal-title":"Middle East J Cancer"},{"issue":"1","key":"15471_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12885-020-6673-2","volume":"20","author":"Y Chong","year":"2020","unstructured":"Chong Y, et al. Prognostic significance of stem cell\/epithelial-mesenchymal transition markers in periampullary\/pancreatic cancers: FGFR1 is a promising prognostic marker. BMC Cancer. 2020;20(1):216.","journal-title":"BMC Cancer"},{"issue":"8","key":"15471_CR53","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.nano.2018.08.001","volume":"14","author":"S Kallus","year":"2018","unstructured":"Kallus S, et al. Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index. Nanomed Nanotechnol Biol Med. 2018;14(8):2632\u201343.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"15471_CR54","unstructured":"La Franca M. Design, synthesis and biological evaluation of new anticancer drugs: FGFR inhibitors. 2021."},{"issue":"20","key":"15471_CR55","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.3390\/molecules27207124","volume":"27","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Hu X. Molecular recognition of FDA-Approved small molecule protein kinase drugs in protein kinases. Molecules. 2022;27(20):7124.","journal-title":"Molecules"},{"key":"15471_CR56","unstructured":"Cheng Y, et al. The investigation of Nf\u03bab inhibitors to block cell proliferation in OSCC cells lines. Curr Med Chem; 2024."},{"key":"15471_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.25259\/Cytojournal_137_2024","volume":"21","author":"W Yuan","year":"2024","unstructured":"Yuan W, et al. Surfeit 4 regulates aerobic Glycolysis to enhanced proliferation, tumor stemness, invasion, and metastasis in oral squamous cell carcinoma. Cytojournal. 2024;21:60.","journal-title":"Cytojournal"},{"issue":"9","key":"15471_CR58","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1021\/acs.jcim.9b01162","volume":"60","author":"S Korkmaz","year":"2020","unstructured":"Korkmaz S. Deep learning-based imbalanced data classification for drug discovery. J Chem Inf Model. 2020;60(9):4180\u201390.","journal-title":"J Chem Inf Model"},{"key":"15471_CR59","doi-asserted-by":"crossref","unstructured":"Altalhan M, Algarni A, Alouane MT-H. Imbalanced data problem in machine learning: A review. IEEE Access; 2025.","DOI":"10.1109\/ACCESS.2025.3531662"},{"key":"15471_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fchem.2018.00362","volume":"6","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Dehnbostel FO, Preissner R. Prediction is a balancing act: importance of sampling methods to balance sensitivity and specificity of predictive models based on imbalanced chemical data sets. Front Chem. 2018;6:362.","journal-title":"Front Chem"},{"issue":"1","key":"15471_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13321-019-0350-y","volume":"11","author":"K Vukovic","year":"2019","unstructured":"Vukovic K, Gadaleta D, Benfenati E. Methodology of aiqsar: a group-specific approach to QSAR modelling. J Cheminform. 2019;11(1):27.","journal-title":"J Cheminform"},{"key":"15471_CR62","first-page":"283","volume-title":"Machine learning evaluation of imbalanced health data: a comparative analysis of balanced accuracy, MCC, and F1 score. Practical statistical learning and data science methods: case studies from LISA 2020 global Network, USA","author":"R Diallo","year":"2024","unstructured":"Diallo R, Edalo C, Awe OO. Machine learning evaluation of imbalanced health data: a comparative analysis of balanced accuracy, MCC, and F1 score. Practical statistical learning and data science methods: case studies from LISA 2020 global Network, USA. Springer; 2024. pp. 283\u2013312."},{"issue":"2","key":"15471_CR63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.60084\/mp.v2i2.217","volume":"2","author":"TR Noviandy","year":"2024","unstructured":"Noviandy TR, et al. Application of ensemble machine learning methods for QSAR classification of leukotriene A4 hydrolase inhibitors in drug discovery. Malacca Pharm. 2024;2(2):68\u201378.","journal-title":"Malacca Pharm"},{"key":"15471_CR64","doi-asserted-by":"publisher","first-page":"1581398","DOI":"10.3389\/fimmu.2025.1581398","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng X, et al. PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1. Front Immunol. 2025;16:1581398.","journal-title":"Front Immunol"},{"issue":"5","key":"15471_CR65","doi-asserted-by":"publisher","first-page":"e0197734","DOI":"10.1371\/journal.pone.0197734","volume":"13","author":"CR Ellis","year":"2018","unstructured":"Ellis CR, et al. Predicting opioid receptor binding affinity of Pharmacologically unclassified designer substances using molecular Docking. PLoS ONE. 2018;13(5):e0197734.","journal-title":"PLoS ONE"},{"issue":"4","key":"15471_CR66","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/molecules25040823","volume":"25","author":"T Mohammad","year":"2020","unstructured":"Mohammad T, et al. Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: combined molecular Docking and simulation studies. Molecules. 2020;25(4):823.","journal-title":"Molecules"},{"key":"15471_CR67","doi-asserted-by":"crossref","unstructured":"Lu Y, et al. Discovery and characterization of novel FGFR1 V561M inhibitors via virtual screening and molecular dynamics simulations. ACS Medicinal Chemistry Letters; 2025.","DOI":"10.1021\/acsmedchemlett.5c00205"},{"key":"15471_CR68","doi-asserted-by":"publisher","first-page":"130708","DOI":"10.1016\/j.ijbiomac.2024.130708","volume":"264","author":"X Guo","year":"2024","unstructured":"Guo X, et al. Recent advancements in hydrogels as novel tissue engineering scaffolds for dental pulp regeneration. Int J Biol Macromol. 2024;264:130708.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"15471_CR69","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.62347\/MJOA5699","volume":"16","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Predictive and prognostic value of combined detection of sTim-3, PG and PD-L1 in immune checkpoint inhibitor therapy for advanced gastric cancer. Am J Transl Res. 2024;16(11):6955\u201363.","journal-title":"Am J Transl Res"},{"issue":"30","key":"15471_CR70","doi-asserted-by":"publisher","first-page":"1611571","DOI":"10.3389\/pore.2024.1611571","volume":"18","author":"S Sakurai","year":"2024","unstructured":"Sakurai S, Ishida Y, Shintani T, Yamasaki S, Matsui K, Hamana T, et al. Clinical significance of integrin \u03b1V and \u03b2 superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study. Pathol Oncol Res. 2024;18(30):1611571. PMID: 38312516; PMCID: PMC10830843. https:\/\/doi.org\/10.3389\/pore.2024.1611571.","journal-title":"Pathol Oncol Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15471-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15471-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15471-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:24Z","timestamp":1769609004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15471-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15471"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15471-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the current form of manuscript and agreed to submit.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}